insights_auto
Outlook: 62.5% bullish·6.2% bearish
Go to analysischevron_right
INCY:NASDAQ
Incyte Corp
121,35 $
arrow_downward
-1,50%(-1,85) 1D
121,35 $
0,00% (0,00)
bedtimeAfter hours
Closed: 30 қыр., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INCY...
Open
123,00 $
High
124,23 $
Low
121,03 $
Mkt. cap
24,60 млрд
Avg. vol.
1,41 млн
Volume
0,00
P/E ratio
15,46
52-wk high
132,58 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,77
Shares outstanding
202,70 млн
No. of employees
3 мың
Open
123,00 $
High
124,23 $
Low
121,03 $
Mkt. cap
24,60 млрд
Avg. vol.
1,41 млн
Volume
0,00
P/E ratio
15,46
52-wk high
132,58 $
52-wk low
82,82 $
EPS
7,85 $
Beta
0,77
Shares outstanding
202,70 млн
No. of employees
3 мың
News stories
From web sources and news partners
News Corp
·
8 сағат бұрын
Incyte Corp. stock outperforms competitors despite losses on the day
Zacks
·
13 сағат бұрын
INCY or TECH: Which Is the Better Value Stock Right Now?
Yahoo Finance
·
14 сағат бұрын
INCY or TECH: Which Is the Better Value Stock Right Now?
The Global Legal Post
·
22 сағат бұрын
Diabetes tech company MiniMed hires ex-Incyte GC as next legal head
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2,84 мың
Founded2002
HeadquartersWilmington, Делавэр, Америка Құрама Штаттары
Sector-
Websiteincyte.com